Table 3 Characteristics of survivors vs. non-survivors

Male sex

73 (54.5)

65 (51.2)

0.59

Median age (range)

64 (22–95)

65 (24–101)

0.81

Ward type

<0.001 ^a

 Medical ward

66 (49.3)

44 (34.6)

 Surgical ward

37 (27.6)

14 (11.0)

 ICU

31 (23.1)

69 (54.3)

Elective admission

14 (10.4)

13 (10.2)

0.96

Malignancies

58 (43.3)

48 (51.6)

0.37

Diabetes

53 (39.6)

50 (39.4)

0.97

Chronic renal failure

22 (16.4)

45 (35.4)

<0.001

Hepatobiliary disorders

25 (18.7)

33 (26.0)

0.16

Myocardial infarction

19 (14.2)

24 (18.9)

0.30

Cerebrovascular disease

11 (8.2)

18 (14.2)

0.13

Median (range) Charlson score

4 (0–15)

5 (0–14)

0.09^a

Median (range) SAPS II score

43 (14–82)

58 (27–103)

<0.001 ^a

Central venous catheter

89 (66.4)

103 (81.1)

0.007 ^a

Drain

37 (27.6)

23 (18.1)

0.07^a

Mechanical ventilation

47 (35.1)

64 (50.4)

0.01 ^a

Total parenteral nutrition

28 (20.9)

24 (18.9)

0.69

Surgery

81 (60.4)

89 (70.1)

0.10

 Gastrointestinal surgery

20 (14.9)

21 (16.5)

0.72

Renal replacement therapy

23 (17.2)

62 (48.8)

<0.001 ^a

Antimicrobial therapy

116 (86.6)

120 (94.5)

0.30

Antifungal therapy

27 (20.1)

24 (18.9)

0.79

Immunosuppressive therapy

33 (24.6)

43 (33.9)

0.10

Neutropenia

10 (7.5)

11 (8.7)

0.72

Initial therapy

<0.001 ^b

 Echinocandin

89 (66.4)

76 (59.8)

 Azole

40 (29.9)

12 (9.4)

 Others (Amphotericin or combination)

3 (2.2)

5 (3.9)

 None

2 (1.5)

34 (26.8)

Received initial therapy within 24 h

58 (43.2)

64 (50.4)

<0.001 ^b

Species

0.04 ^a

 C. albicans

32 (23.9)

27 (21.3)

 C. glabrata

39 (29.1)

36 (28.3)

 C. tropicalis

29 (21.6)

42 (33.1

 C. parapsilosis

24 (17.9)

9 (7.1)

Median (range) time to reporting positive culture, days

2 (0–10)

2 (0–10)

0.08^a

Median (range) time to species identification, days

5 (2–16)

5 (2–22)

0.001 ^a

Median (range) Candida score

2 (0–5)

3 (0–5)

0.01

Median (range) Pitts' bacteraemia score

2 (0–11)

5 (0–14)

<0.001 ^a

Severe sepsis at time of culture

64 (47.8)

87 (68.5)

0.001 ^a

Concurrent bacterial infection

59 (46.5)

68 (53.5)

0.12

Candida colonization/infection at other sites

61 (45.5)

57 (44.9)

0.92